AmSurg (AMSG) Tops Q4 EPS by 4c, Guides FY EPS Above Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Equities close higher as softer jobs data quiets rate-hike expectations
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
AmSurg Reports 21% Growth in Fourth-Quarter Net Revenues, 39% Growth in Adjusted Diluted EPS of $1.07 and Diluted EPS of $1.26
February 24, 2016 4:05 PM ESTProvides 2016 Financial Guidance
NASHVILLE, Tenn.--(BUSINESS WIRE)-- AmSurg Corp. (NASDAQ: AMSG) today announced financial results for the fourth quarter and year ended December 31, 2015. The Companys results for the quarter included:
Growth of 21% in net revenues to $704.3 million from $581.8 million for the fourth quarter of 2014; Net earnings from continuing operations attributable to AmSurg common shareholders of $64.3 million and adjusted net earnings of $56.7 million, up 43% compared with the fourth quarter of 2014; Net earnings per diluted share from continuing operations... More